Expanding Your Medical Affairs Impact: Strategic Engagement Beyond the Prescribing Physician
January 16, 2026 @ 10:00 AM – 11:00 AM EST
In today’s complex healthcare landscape, patient outcomes depend on a diverse network of stakeholders far beyond the prescribing physician. Join us as we explore why traditional Medical Affairs engagement models need to evolve and examine strategies for building meaningful relationships with nurses, pharmacists, patients, advocacy groups, and other influential voices in healthcare delivery.
Whether you’re considering broadening your current engagement strategy or looking to understand the evolving Medical Affairs landscape, this session will provide valuable insights and practical guidance for multi-stakeholder engagement.
Learning Objectives
- Recognize key non-prescribing stakeholder groups that influence patient outcomes in modern healthcare delivery.
- Gain insights on why traditional Medical Affairs engagement models need to evolve to address today’s complex healthcare landscape.
- Determine successful strategies and practical approaches for engaging diverse healthcare stakeholders based on real-world industry experiences.
Speakers:
Moderator:
Helen Langan
EVP, Medical Affairs Strategy and Transformation
HCG
Speaker:
Lucy Turner
Medical Lead, GI Cancers and Emerging Portfolio, Europe and Canada
AstraZeneca
Speaker:
Gurinder S. Sidhu
U.S. Antiviral Medical Lead, Senior Director
Pfizer
Speaker:
Alex Schepart, PharmD, MBA
Senior Director, Medical Affairs
Shionogi Inc.
